Abstract
Introduction Herd-immunity is the practice by which an immunized portion of a population or herd confers a measure of protection for individuals who have not been immunized. While commonly associated with vector vaccination, it offers the same practical approach to aseptic strategies in the hospital. In theory, the more decontaminated surfaces in a hospital, the greater immunity conferred to patients against the spread of nosocomial infections. The aim of this study was to evaluate the effectiveness of UV lights in preventing the spread of a DNA tracer from room-to-room in an ICU.
Methods In a prospective trial, a non-pathogenic DNA virus was inoculated onto a variety of high-touch surfaces in an ICU patient room. Investigators swabbed frequently touched surfaces in non-inoculated ICU rooms at 24, 48, and 96-hours post inoculation. Culture specimens were analyzed for the presence of viral DNA via PCR. After baseline data was obtained, focused UV lights were deployed to cover frequently touched surfaces in the ICU including vitals monitors, ventilators, keyboards, dialysis machines and IV pumps. Inoculation and culturing were then repeated.
Results Prior to UV implementation, the DNA tracer disseminated to 10% of tested surfaces in noninoculated rooms at 48 hours. Post UV light deployment, only 1.2% of surfaces tested positive for the DNA tracer after 48 hours.
Conclusion UV decontamination significantly and meaningfully retarded the spread of the mosaic virus DNA across ICU surfaces with a relative reduction in 90% of surfaces contaminated at 48-hours from 10.10% of surfaces pre-UV to 1.20% of surfaces post-UV (p < 0.0001). Realtime UV decontamination holds the potential to confer protection to ICU patients by reducing the number of surfaces that can serve as a nidus for infection transmission.
Highlights
Even with standard cleaning, a mosaic virus spread to 10% of surfaces in the ICU.
Post UV light deployment, only 1.2% of surfaces tested positive for the DNA tracer.
UV light retarded the spread of DNA virus with a reduction of 90% at 48-hours.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was self funded. The UV lights were provided by the manufacturer on a free short term lease.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authors have no conflicts of interest to declare
Data Availability
Raw data available upon request.